Inventor · disambiguated record
Peter T. Lansbury
Also filed as: LANSBURY JR PETER T · LANSBURY PETER · LANSBURY PETER T · LANSBURY PETER T JR
23 granted patents·25 pending applications·515 citations·filing 1992–2024
96Inventor score
Files withLYSOSOMAL THERAPEUTICS INC14BIAL R&D INVEST S A12BRIGHAM & WOMENS HOSPITAL6BIAL—BIOTECH INVEST INC4LINK MEDICINE CORP4
Top patents by PatentIndex Score
48 records- 0196US11091492B2Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Aug 17, 2021·5 cites·38 claims
- 0296US10786508B2Substituted imidazo[1,5-A]-pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2018·Granted Sep 29, 2020·10 cites·30 claims
- 0396US10751341B2Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2019·Granted Aug 25, 2020·12 cites·35 claims
- 0496US9732089B2Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2017·Granted Aug 15, 2017·20 cites·28 claims
- 0595US11932645B2Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2021·Granted Mar 19, 2024·2 cites·20 claims
- 0695US9920061B2Imidazo[1,5-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2017·Granted Mar 20, 2018·16 cites·30 claims
- 0795US9868742B2Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b] pyridazines, related compounds, and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2017·Granted Jan 16, 2018·17 cites·30 claims
- 0895US9840510B1Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2017·Granted Dec 12, 2017·16 cites·30 claims
- 0994US11351173B2Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Jun 7, 2022·3 cites·19 claims
- 1094US10570135B2Substituted pyrazolo[1,5-A]pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2015·Granted Feb 25, 2020·13 cites·18 claims
- 1194US5399665ABiodegradable polymers for cell transplantationMASSACHUSETTS INST TECHNOLOGY·Filed 1992·Granted Mar 21, 1995·311 cites·23 claims
- 1293US10934298B2Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disordersBIAL—BIOTECH INVEST INC·Filed 2019·Granted Mar 2, 2021·10 cites·30 claims
- 1392US11400095B2Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Aug 2, 2022·2 cites·16 claims
- 1491US10787454B2Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersBIAL BIOTECH INVEST INC·Filed 2017·Granted Sep 29, 2020·10 cites·24 claims
- 1590US11453675B2Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Sep 27, 2022·2 cites·18 claims
- 1690US11168087B2Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2017·Granted Nov 9, 2021·4 cites·18 claims
- 1789US11878979B2Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2021·Granted Jan 23, 2024·1 cites·22 claims
- 1886US11192892B2Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disordersBIAL—BIOTECH INVEST INC·Filed 2017·Granted Dec 7, 2021·4 cites·18 claims
- 1986US2025066364A1Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL R&D INVEST S A·Filed 2024·Application pending·0 cites
- 2083US11124516B2Pyrrolo[1,2-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersBIAL—BIOTECH INVEST INC·Filed 2017·Granted Sep 21, 2021·4 cites·16 claims
- 2181US11345698B2Substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-a]pyrazines, related compounds, and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2017·Granted May 31, 2022·3 cites·17 claims
- 2275US12116369B2Substituted pyrazolo[1,5-a]pyrimidines as glucocerebrosidase activatorsBIAL—R&D INVEST S A·Filed 2021·Granted Oct 15, 2024·0 cites·22 claims
- 2375US6054114AOrganometallic ligands for the localization and quantification of amyloid in vivo and in vitroMASSACHUSETTS INST TECHNOLOGY·Filed 1997·Granted Apr 25, 2000·48 cites·2 claims
- 2466US8232402B2Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indicationsLANSBURY JR PETER T·Filed 2009·Granted Jul 31, 2012·2 cites·90 claims
- 2558US2018185368A1Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2657US2007293539A1Methods for the treatment of synucleinopathiesLANSBURY PETER T·Filed 2007·Application pending·0 cites
- 2754US2010160372A1Treatment of proteinopathies using a farnesyl transferase inhibitorLINK MEDICINE CORP·Filed 2009·Application pending·0 cites
- 2852US2022380319A1Substituted benzimidazole carboxamides and their use in the treatment of medical disordersBIAL R&D INVEST S A·Filed 2020·Application pending·0 cites
- 2951US2005277629A1Methods for the treatment of synucleinopathies (Lansbury)BRIGHAM & WOMENS HOSPITAL·Filed 2005·Application pending·0 cites
- 3051US2022411388A1Substituted imidazole carboxamides and their use in the treatment of medical disordersBIAL R&D INVEST S A·Filed 2020·Application pending·0 cites
- 3151US2005272722A1Methods for the treatment of synucleinopathiesBRIGHAM & WOMENS HOSPITAL·Filed 2005·Application pending·0 cites
- 3250US2011294794A1Treatment of proteinopathies using a farnesyl transferase inhibitorLANSBURY JR PETER T·Filed 2009·Application pending·0 cites
- 3349US2017333435A1Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3444US2018369210A1Methods and compositions for treating lysosomal storage disordersLYSOSOMAL THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3542US2005288298A1Methods for the treatment of synucleinopathiesBRIGHAM & WOMENS HOSPITAL·Filed 2005·Application pending·0 cites
- 3642US2006106060A1Methods for the treatment of synucleinopathies (Lansbury)BRIGHAM & WOMENS HOSPITAL·Filed 2005·Application pending·0 cites
- 3741US2010184803A1Treatment of Lysosomal Storage DiseasesGRAMMATOPOULOS TOM·Filed 2008·Application pending·0 cites
- 3841US2006194821A1Compounds inhibiting the aggregation of superoxide dismutase-1BRIGHAM & WOMENS HOSPITAL·Filed 2006·Application pending·0 cites
- 3941US2019389865A1SUBSTITUTED PYRROLO[1,2-a]TRIAZINES AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERSLYSOSOMAL THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4041US2005272068A1UCH-L1 expression and cancer therapyBRIGHAM & WOMENS HOSPITAL·Filed 2005·Application pending·0 cites
- 4139US2019092789A1Heterobicyclic pyrimidinone compounds and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4238US2019112316A1Thiazolo[3,2-a] pyrimidinone and other heterobicyclic pyrimidinone compounds for use in medical therapyLYSOSOMAL THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4338US2018369211A1Methods and compositions for treating neurodegenerative disordersLYSOSOMAL THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4437US2007213366A1Treatment of SynucleinopathiesJUSTMAN CRAIG J·Filed 2006·Application pending·0 cites
- 4537US2011136867A1Treatment of SynucleinopathiesJUSTMAN CRAIG J·Filed 2007·Application pending·0 cites
- 4636US2010292292A1Treatment of Neurodegenerative Diseases Using Indatraline AnalogsLINK MEDICINE CORP·Filed 2008·Application pending·0 cites
- 4729US2010331363A1Treatment of mitochondrial disorders using a farnesyl transferase inhibitorLINK MEDICINE CORP·Filed 2010·Application pending·0 cites
- 4829US2011060005A1Treatment of mitochondrial disorders using a farnesyl transferase inhibitorLINK MEDICINE CORP·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter T. Lansbury files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →